Cleveland Jewish News: William Schiemann, associate professor of general medical sciences, led a team of researchers who found a link between a micro ribonucleic acid molecule and late-stage breast cancer. “Our micro RNA inactivates [a protein called] Bim, and we think this leads to chemo resistance to these metastatic cancers,” Schiemann said. Lower Bim levels, coupled with higher miR-181a levels, allow the spread of cancer.
Medicine’s William Schiemann and researchers target molecule’s role in late-stage breast cancer
- 5 questions with… cancer disparities researcher Monica Webb Hooper
- Biology’s Valerie Haywood presents at American Society of Plant Biologists annual conference
- Donate blood at Aug. 25 American Red Cross drive
- Law’s Erik M. Jensen gives his take on benefits of the Electoral College
- Law’s Jonathan Entin pens two chapters for new books, two articles for “The Federal Lawyer”